A look into Outlook Therapeutics Inc (OTLK)’s deeper side

With 1.08 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.0 million shares. The 52-week range on OTLK shows that it touched its highest point at $2.03 and its lowest point at $0.20 during that stretch. It currently has a 1-year price target of $2.22. Beta for […]

Top investors say Outlook Therapeutics Inc (OTLK) ticks everything they need

With 0.8 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.0 million shares. The 52-week range on OTLK shows that it touched its highest point at $2.03 and its lowest point at $0.20 during that stretch. It currently has a 1-year price target of $2.22. Beta for […]